Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
3.9%
% of FHLC's 372 holdings also in XDNA
60.9%
% of XDNA's 23 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 5.1% | 3.8% | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% | 9.5% | 3.6% |
|
BRISTOL-MYERS SQUIBB CO | 1.7% | 1.6% | 1.6% |
|
VERTEX PHARMACEUTICALS INC | 1.8% | 1.5% | 1.5% |
|
REGENERON PHARMACEUTICALS | 1.7% | 1.3% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to XDNA
|
ELI LILLY & CO | 10.2% |
|
UNITEDHEALTH GROUP INC | 7.3% |
|
JOHNSON & JOHNSON | 6.3% |
|
MERCK & CO. INC. | 5.2% |
|
ABBOTT LABORATORIES | 3.3% |
|
DANAHER CORP | 2.9% |
|
PFIZER INC | 2.4% |
|
AMGEN INC | 2.4% |
|
INTUITIVE SURGICAL INC | 2.3% |
|
STRYKER CORP | 2.0% |
FHLC Underweight Relative to XDNA
|
CRISPR THERAPEUTICS AG | -15.0% |
|
BEAM THERAPEUTICS, INC. | -13.6% |
|
INTELLIA THERAPEUTICS, INC. | -8.6% |
|
THERMO FISHER SCIENTIFIC INC | -5.9% |
|
PRIME MEDICINE, INC. | -5.9% |
|
EDITAS MEDICINE, INC. | -5.7% |
|
CARIBOU BIOSCIENCES, INC. | -4.7% |
|
VERVE THERAPEUTICS, INC. | -4.5% |
|
POSEIDA THERAPEUTICS, INC. | -4.1% |
|
ALLOGENE THERAPEUTICS, INC. | -3.4% |